The Value of Adrenal Imaging in Adrenal Surgery

  • Bruno Niederle
  • Gertraud Heinz-Peer
  • Klaus Kaczirek
  • Amir Kurtaran


Primary Aldosteronism Adrenal Tumor Laparoscopic Adrenalectomy Adrenal Lesion Chemical Shift Image 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F (2000) Adrenal incidentaloma. Braz J Med Biol Res 33:1177–1189CrossRefPubMedGoogle Scholar
  2. 2.
    Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE (2000) Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 128:973–982; discussion 982–983CrossRefPubMedGoogle Scholar
  3. 3.
    Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998) Can adrenal incidentalomas be safely observed? World J Surg 22:599–603; discussion 603–604CrossRefPubMedGoogle Scholar
  4. 4.
    Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M (1999) Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520–526CrossRefPubMedGoogle Scholar
  5. 5.
    Berglund S, Hulthen UL, Manhem P (2001) Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. J Intern Med 249: 247–251CrossRefPubMedGoogle Scholar
  6. 6.
    Bergstrom M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstrom G, Langstrom B (2000) PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11Cmetomidate. J Nucl Med 41:275–282PubMedGoogle Scholar
  7. 7.
    Biersack HJ, Grunwald F (1995) Endocrinological applications in nuclear medicine. Semin Nucl Med 25:92–110PubMedGoogle Scholar
  8. 8.
    Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25:905–913CrossRefPubMedGoogle Scholar
  9. 9.
    Choyke PL (1998) From needles to numbers: can noninvasive imaging distinguish benign and malignant adrenal lesions? World J Urol 16:29–34CrossRefPubMedGoogle Scholar
  10. 10.
    Dackiw AP, Lee JE, Gagel RF, Evans DB (2001) Adrenal cortical carcinoma. World J Surg 25:914–926CrossRefPubMedGoogle Scholar
  11. 11.
    Doppman JL (1996) Hyperaldosteronism: Sampling the adrenal veins. Radiology 198:309–312PubMedGoogle Scholar
  12. 12.
    Duh QY (2002) Adrenal incidentalomas. Br J Surg 89:1347–1349CrossRefPubMedGoogle Scholar
  13. 13.
    Favia G, Lumachi F, Basso S, D’Amico DF (2000) Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 128:918–924CrossRefPubMedGoogle Scholar
  14. 14.
    Freitas JE, Thrall JH, Swanson DP, Rifai A, Beierwaltes WH (1975) Normal adrenal asymmetry: explanation and interpretation. J Nucl Med 19:149–154Google Scholar
  15. 15.
    Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A (1997) Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226:238–246; discussion 246–247CrossRefPubMedGoogle Scholar
  16. 16.
    Geelhoed GW, Druy EM (1983) Adrenal radiography: problems and pitfalls in adrenal localization. World J Surg 7:209–222CrossRefPubMedGoogle Scholar
  17. 17.
    Glazer GM (1988) MR imaging of the liver, kidneys, and adrenal glands. Radiology 166:303–312PubMedGoogle Scholar
  18. 18.
    Gross MD, Freitas JE, Swanson DP, Brady T, Beierwaltes WH (1979) The normal dexamethasone-suppression adrenal scintiscan. J Nucl Med 20:1131–1135PubMedGoogle Scholar
  19. 19.
    Gross MD, Thrall JH, Beierwaltes WH (1980) The adrenal scan: a current status report on radiotracers, dosimetry and clinical utility. Nucl Med Annual, Raven Press, New York, pp 27–175Google Scholar
  20. 20.
    Gross MD, Valk TW, Swanson DP, Thrall JH, Grekin RJ, Beirewaltes WH (1981) The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin Nucl Med 11:128–148PubMedGoogle Scholar
  21. 21.
    Gross MD, Shapiro B, Grekin RJ, Freitas JE, Glazer G, Beierwaltes WH, Thompson NW (1984) Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med 77:839–844CrossRefPubMedGoogle Scholar
  22. 22.
    Gross MD, Shapiro B, Bouffard JA, Glazer GM, Francis IR, Wilton GP, Khafagi F, Sonda LP (1988) Distinguishing benign from malignant euadrenal masses. Ann Intern Med 109:613–618PubMedGoogle Scholar
  23. 23.
    Gross MD, Shapiro B (1989) Scintigraphic studies in adrenal hypertension. Semin Nucl Med 19:122–143PubMedGoogle Scholar
  24. 24.
    Gross MD, Shapiro B, Francis IR, Glazer GM, Bree RL, Arcomano MA, Schteingart DE, McLeod MK, Sanfield JA, Thompson NW (1994) Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 35:1145–1152PubMedGoogle Scholar
  25. 25.
    Gross MD, Shapiro B, Francis IR, Bree RL, Korobkin M, McLeod MK, Thompson NW, Sanfield JA (1995) Scintigraphy of incidentally discovered bilateral adrenal masses. Eur J Nucl Med 22:315–321CrossRefPubMedGoogle Scholar
  26. 26.
    Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand% HS (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429PubMedGoogle Scholar
  27. 27.
    Heinz-Peer G, Honigschnabl S, Schneider B, Niederle B, Kaserer K, Lechner G (1999) Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol 173:15–22PubMedGoogle Scholar
  28. 28.
    Henry JF, Defechereux T, Gramatica L, Raffaelli M (1999) Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langenbecks Arch Surg 384:366–369CrossRefPubMedGoogle Scholar
  29. 29.
    Henry JF, Sebag F, Iacobone M, Mirallie E (2002) Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 26:1043–1047CrossRefPubMedGoogle Scholar
  30. 30.
    Hönigschnabl S (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41:113–122CrossRefPubMedGoogle Scholar
  31. 31.
    Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, Reznek R, Monson JP, Besser GM, Foley R, Britton KE, Grossman AB (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86:895–902CrossRefGoogle Scholar
  32. 32.
    Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC (1989) Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30:481–489PubMedGoogle Scholar
  33. 33.
    Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484Google Scholar
  34. 34.
    Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD, Thompson NW (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418PubMedGoogle Scholar
  35. 35.
    Korobkin M, Giordano TJ, Brodeur FJ, Francis R, Siegelman ES, Quint LE, Dunnick NR, Heiken JP, Wang HH (1996) Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743–747PubMedGoogle Scholar
  36. 36.
    Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747–752PubMedGoogle Scholar
  37. 37.
    Kouriefs C (1999) Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg 86:385–387CrossRefPubMedGoogle Scholar
  38. 38.
    Kouriefs C, Mokbel K, Choy C (2001) Is MRI more accurate than CT in estimating the real size of adrenal tumours? Eur J Surg Oncol 27:487–490CrossRefPubMedGoogle Scholar
  39. 39.
    Krestin GP, Steinbrich W, Friedmann G (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171:675–680PubMedGoogle Scholar
  40. 40.
    Krestin GP, Freidmann G, Fishbach R, Neufang KF, Allolio B (1991) Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 15:104–110PubMedGoogle Scholar
  41. 41.
    Lau H, Lo CY, Lam KY (1999) Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg 86:385–387CrossRefPubMedGoogle Scholar
  42. 42.
    Linos DA, Stylopoulos N (1997) How accurate is computed tomography in predicting the real size of adrenal tumors? A retrospective study. Arch Surg 132:740–743PubMedGoogle Scholar
  43. 43.
    Lockhart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41:95–112CrossRefPubMedGoogle Scholar
  44. 44.
    Ludvik B, Niederle B, Roka R, Längle F, Neuhold N, Templ M, G. S (1993) Isolated primary aldosteronism in adrenocortical carcinoma: a case report and review of the literature. Acta Chir Austriaca 25:212–216Google Scholar
  45. 45.
    Lumachi F, Zucchetta P, Marzola MC, Bui F, Casarrubea G, Angelini F, Favia G (2002) Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing’s syndrome. Nucl Med Commun 23:469–473CrossRefPubMedGoogle Scholar
  46. 46.
    Lumachi F, Borsato S, Tregnaghi A, Basso SM, Marchesi P, Ciarleglio F, Fassina A, Favia G (2003) CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29:689–692CrossRefPubMedGoogle Scholar
  47. 47.
    Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW (2001) Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066–1071CrossRefPubMedGoogle Scholar
  48. 48.
    Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644CrossRefPubMedGoogle Scholar
  49. 49.
    Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M (1999) Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173:25–29PubMedGoogle Scholar
  50. 50.
    Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M (2001) The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med 42:884–892PubMedGoogle Scholar
  51. 51.
    Miccoli P, Raffaelli M, Berti P, Materazzi G, Massi M, Bernini G (2002) Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg 89: 779–782CrossRefPubMedGoogle Scholar
  52. 52.
    Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185:345–351PubMedGoogle Scholar
  53. 53.
    Nacaudie-Calzade M, Huglo D, Lambert M (1999) Efficacy of iodine-131-6ß-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronismus. Eur J Nucl Med 26:1326–1332CrossRefPubMedGoogle Scholar
  54. 54.
    Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH (1983) The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 24:672–682PubMedGoogle Scholar
  55. 55.
    Nakajo M, Shapiro B, Glowniak J, Sisson JC, Beierwaltes WH (1983) Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 24:1127–1134PubMedGoogle Scholar
  56. 56.
    Niederle B, Winkelbauer FW, Frilling A (1995) Inzedentaloma der Nebenniere — eine Übersicht. Chir Gastroenterol 11:34–41Google Scholar
  57. 57.
    Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 165:579–583PubMedGoogle Scholar
  58. 58.
    Outwater EK, Siegelman ES, Huang AB, Birnbaum BA (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200: 749–752PubMedGoogle Scholar
  59. 59.
    Pattou FN, Combemale FP, Poirette JF, Carnaille B, Wemeau JL, Huglo D, Ernst O, Proye CA (1996) Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas. Surgery 120:1006–1011; discussion 1012PubMedGoogle Scholar
  60. 60.
    Prager G, Heinz-Peer G, Passler C, Kaczirek K, Schindl M, Scheuba C, Niederle B (2002) Surgical strategy in adrenal masses. Eur J Radiol 41:70–77CrossRefPubMedGoogle Scholar
  61. 61.
    Prager G, Heinz-Peer G, Passler C, Kaczirek K, Schindl M, Scheuba C, Vierhapper H, Niederle B (2002) Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses? World J Surg 26:958–964CrossRefGoogle Scholar
  62. 62.
    Prager G, Heinz-Peer G, Passler C, Kaczirek K, Scheuba C, Niederle B (2004) Applicability of laparoscopic adrenalectomy in 150 consecutive patients — a prospective study. Arch Surg 139:46–49CrossRefPubMedGoogle Scholar
  63. 63.
    Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL (1987) Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165:89–93PubMedGoogle Scholar
  64. 64.
    Reiners C (1994) Nebennierenrinde. In:Büll U, Schicha H, Biersack HJ, Knapp WH, Reiners C, Schober O (eds) Nuklearmedizin. Thieme, StuttgartGoogle Scholar
  65. 65.
    Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J (1996) Oncological applications of positron emission tomography with fl uorine-18 fl uorodeoxyglucose. Eur J Nucl Med 23:1641–1674CrossRefPubMedGoogle Scholar
  66. 66.
    Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86:1083–1090CrossRefPubMedGoogle Scholar
  67. 67.
    Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Barlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, Reincke M (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34:180–186CrossRefPubMedGoogle Scholar
  68. 68.
    Salam Z, Lubbos H, Martinez C, Mozley PD, Miller JL, Rose LI (1996) Case report: failure of adrenal scintigraphy to exhibit 131I cholesterol uptake in a CT-demonstrated, surgically proven aldosteronoma. Am J Med Sci 312:130–132CrossRefPubMedGoogle Scholar
  69. 69.
    Semelka RC, Shoenut JP, Lawrence PH, Greenberg HM, Maycher B, Madden TP, Kroeker MA (1993) Evaluation of adrenal masses with gadolinium enhancement and fatsuppressed MR imaging. J Magn Reson Imaging 3:337–343PubMedGoogle Scholar
  70. 70.
    Shapiro B, Nakajo M, Gross MD, Freitas J, Copp J, Beierwaltes WH (1983) Value of bowel preparation in adrenocortical scintigraphy with NP-59. J Nucl Med 24:732–734PubMedGoogle Scholar
  71. 71.
    Shapiro B, Grekin RJ, Gross MD, Freitas JE (1994) Interference of spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronismus. Clin Nucl Med 19:441–445PubMedGoogle Scholar
  72. 72.
    Shapiro B, Fig LM, Gross MD, Shulkin BL, Sisson JC (1998) Neuroendocrine tumors. In: Aktolun C, Tauxe WN (eds) Nuclear oncology. Springer, Tokyo, pp 3–31Google Scholar
  73. 73.
    Siren J, Tervahartiala P, Sivula A, Haapiainen R (2000) Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 24:579–582CrossRefPubMedGoogle Scholar
  74. 74.
    Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13:513–521PubMedGoogle Scholar
  75. 75.
    Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517–521PubMedGoogle Scholar
  76. 76.
    Van der Harst E, De Herder WW, Bruining HA (2001) Metaiodobenzylguanidine and In-111-Octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 86:685–693CrossRefPubMedGoogle Scholar
  77. 77.
    Whalen RK, Althausen AF, Daniels GH (1992) Extraadrenal pheochromocytoma. J Urol 147:1–10PubMedGoogle Scholar
  78. 78.
    Wheeler MH, Harris DA (2003) Diagnosis and management of primary aldosteronism. World J Surg 27:627–631CrossRefPubMedGoogle Scholar
  79. 79.
    Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH (1980) Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 21:349–353PubMedGoogle Scholar
  80. 80.
    Wieland DM, Brown LE, Tobes MC, Rogers WL, Marsh DD, Mangner TJ, Swanson DP, Beierwaltes WH (1981) Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med 22:358–364PubMedGoogle Scholar
  81. 81.
    Young WF Jr, Hogan MJ, Klee GG, Grant CS, van Heerden JA (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65:96–110PubMedGoogle Scholar
  82. 82.
    Young WF Jr, Stanson AW, Grant CS, Thompson GB, van Heerden JA (1996) Primary aldosteronism: adrenal venous sampling. Surgery 120:913–919; discussion 919–920PubMedGoogle Scholar
  83. 83.
    Yu KC, Alexander HR, Ziessman HA, Norton JA, Doppman JL, Buell JF, Nieman LK, Cutler GB Jr, Chrousos GP, Fraker DL (1995) Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing’s syndrome. Surgery 118:981–986; discussion 986–987PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Bruno Niederle
  • Gertraud Heinz-Peer
  • Klaus Kaczirek
  • Amir Kurtaran

There are no affiliations available

Personalised recommendations